亚太地区自我监测血糖设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按组件(血糖仪设备、试纸和柳叶刀)和地理位置进行细分。

市场快照

Asia-Pacific Self-Monitoring Blood Glucose Devices Market
Study Period: 2016-2027
Base Year: 2021
CAGR: 6.48 %
Asia-Pacific Self-Monitoring Blood Glucose Devices Market Size

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

到 2026 年,亚太地区的自我监测血糖设备市场预计将达到 28 亿美元以上。亚太地区的自我监测血糖 (SMBG) 设备市场仍处于增长阶段。在亚太地区,大约 10% 的糖尿病患者是 1 型糖尿病患者,90% 是 2 型糖尿病患者。1 型患者需要终生服用胰岛素,同时保持健康的饮食和定期的体育锻炼。2型患者需要健康饮食、锻炼身体并定期检查血糖水平。他们可能还需要服用口服药物和胰岛素来控制血液中的葡萄糖水平。糖尿病作为一种疾病,有许多与之相关的并发症,包括糖尿病酮症酸中毒和非酮症高渗性昏迷。严重的长期并发症包括心脏病、中风、肾衰竭、足部溃疡和眼睛损伤。为了避免这些并发症,患者需要定期监测他们的血糖水平以控制他们的血糖水平,因此,患者在血糖仪和试纸的帮助下检查他们的血糖水平。

报告范围

市场按组件(血糖仪设备、试纸和柳叶刀)和地理位置进行细分。该研究对亚太地区自我监测血糖设备的需求和趋势以及国家规模、份额和预测进行了详细分析。

Self-monitoring Blood Glucose Devices
By Component (Value and Volume, 2016 - 2026)
Glucometer Devices
Test Strips
Lancets
By Geography
Asia-Pacific (Value and Volume, 2016 - 2026)
Japan
By Component (Glucometer Device, Test Strips, Lancets)
South Korea
By Component (Glucometer Device, Test Strips, Lancets)
China
By Component (Glucometer Device, Test Strips, Lancets)
India
By Component (Glucometer Device, Test Strips, Lancets)
Australia
By Component (Glucometer Device, Test Strips, Lancets)
Vietnam
By Component (Glucometer Device, Test Strips, Lancets)
Malaysia
By Component (Glucometer Device, Test Strips, Lancets)
Indonesia
By Component (Glucometer Device, Test Strips, Lancets)
Philippines
By Component (Glucometer Device, Test Strips, Lancets)
Thailand
By Component (Glucometer Device, Test Strips, Lancets)
Rest of Asia-Pacific
By Component (Glucometer Device, Test Strips, Lancets)

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计血糖仪部分将在预测期内录得最高的复合年增长率。

由于与血糖仪相关的意识和创新不断提高,预计血糖仪设备市场将在未来几年实现高销售额。血糖仪设备的技术进步将支持血糖仪细分市场的增长。血糖仪公司设计的智能血糖仪设备现已连接到移动设备,可帮助糖尿病患者、他们的父母或朋友在关键时刻立即了解他们的健康状况。即使是拥有移动应用程序(如罗氏的 Mysugar 日志应用程序)的公司,以及没有移动应用程序的公司也在尝试制造血糖仪,以便它们可以与所有糖尿病移动应用程序一起使用。Arcadia Group 设计了连接到 Aggamatrix 创建的移动设备的智能血糖仪设备。为此,两家公司在 2018 年,

Asia-Pacific Self-Monitoring Blood Glucose Devices Market Trend

2020年中国市场份额在亚太地区最高

预计中国市场在预测期内将增长,复合年增长率为 6.58%。2020年我国糖尿病患者约1.268亿人,成人患病率为11.2%。1.268亿糖尿病患者中,1型糖尿病1249万人,2型糖尿病11432万人。预计这些数字将在预测期内增加。中国在亚太地区血糖仪设备市场占有最高的市场份额。在中国,由于生活方式和饮食习惯,胰岛素使用者的血糖波动不时频繁。中国是一个成熟的市场,伴随着经济增长缓慢和人口老龄化的挑战。2020年中国血糖监测设备市场耗材占比87.0%,其中85款。

Asia-Pacific Self-Monitoring Blood Glucose Devices Market Report

竞争格局

亚太地区自我监测血糖设备市场分散,少数主要制造商在亚太市场的主要国家/地区占有一席之地,而其余市场则由其他本地或特定区域的制造商组成。近期参与者之间发生的并购有助于这些公司加强其市场占有率。 

RECENT DEVELOPMENTS

In Jan 2020, Roche Diabetes Care (RDC) India has announced the launch of its new Accu-Chek Guide blood glucose monitoring system, which offers unique features and an innovative design that makes it easy to use. The new Accu-Chek Guide SmartPack test strip vial is spill-resistant. It holds test strips tightly in place while also making it easy to remove just one strip at a time.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Self-monitoring Blood Glucose Devices

      1. 5.1.1 By Component (Value and Volume, 2016 - 2026)

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

    2. 5.2 By Geography

      1. 5.2.1 Asia-Pacific (Value and Volume, 2016 - 2026)

        1. 5.2.1.1 Japan

          1. 5.2.1.1.1 By Component (Glucometer Device, Test Strips, Lancets)

        2. 5.2.1.2 South Korea

          1. 5.2.1.2.1 By Component (Glucometer Device, Test Strips, Lancets)

        3. 5.2.1.3 China

          1. 5.2.1.3.1 By Component (Glucometer Device, Test Strips, Lancets)

        4. 5.2.1.4 India

          1. 5.2.1.4.1 By Component (Glucometer Device, Test Strips, Lancets)

        5. 5.2.1.5 Australia

          1. 5.2.1.5.1 By Component (Glucometer Device, Test Strips, Lancets)

        6. 5.2.1.6 Vietnam

          1. 5.2.1.6.1 By Component (Glucometer Device, Test Strips, Lancets)

        7. 5.2.1.7 Malaysia

          1. 5.2.1.7.1 By Component (Glucometer Device, Test Strips, Lancets)

        8. 5.2.1.8 Indonesia

          1. 5.2.1.8.1 By Component (Glucometer Device, Test Strips, Lancets)

        9. 5.2.1.9 Philippines

          1. 5.2.1.9.1 By Component (Glucometer Device, Test Strips, Lancets)

        10. 5.2.1.10 Thailand

          1. 5.2.1.10.1 By Component (Glucometer Device, Test Strips, Lancets)

        11. 5.2.1.11 Rest of Asia-Pacific

          1. 5.2.1.11.1 By Component (Glucometer Device, Test Strips, Lancets)

  6. 6. MARKET INDICATORS

    1. 6.1 Type 1 Diabetes Population (2016 - 2026)

    2. 6.2 Type 2 Diabetes Population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Abbott

      2. 7.1.2 F. Hoffmann-La Roche AG

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Arkray

      5. 7.1.5 Ascensia Diabetes Care

      6. 7.1.6 Agamatrix

      7. 7.1.7 Bionime Corporation

      8. 7.1.8 Acon

      9. 7.1.9 Medisana

      10. 7.1.10 Trivida

      11. 7.1.11 I-Sens

      12. 7.1.12 Morpen Laboratories

      13. 7.1.13 Rossmax International

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Self-monitoring Blood Glucose Devices Market market is studied from 2016 - 2027.

The Asia-Pacific Self-monitoring Blood Glucose Devices Market is growing at a CAGR of 6.48% over the next 5 years.

The Asia-Pacific Self-monitoring Blood Glucose Devices Market is valued at 1 Billion USD in 2016.

The Asia-Pacific Self-monitoring Blood Glucose Devices Market is valued at 2 Billion USD in 2027.

F. Hoffmann-La Roche AG, Abbott, Ascensia, I-Sens, Morepen Laboratories are the major companies operating in Asia-Pacific Self-monitoring Blood Glucose Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!